Case 1. Metastatic breast cancer presenting with panhypopituitarism

被引：6

作者：

Khandwala, HM ^{[1
]}

Mirchandani, D

Chibbar, R

Chow, V

机构：

[1] Univ Saskatchewan, Dept Med, Div Endocrinol, Saskatoon, SK S7N 0W0, Canada

[2] Univ Saskatchewan, Dept Pathol & Radiol, Saskatoon, SK, Canada

[3] Univ Saskatchewan, Dept Med Oncol, Saskatoon Canc Ctr, Saskatoon, SK, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 23期

关键词：

D O I：

10.1200/JCO.2004.11.098

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：4851 / 4853

页数：3

共 10 条

[1] METASTATIC TUMORS TO THE PITUITARY [J].

AABERG, JM ;

KAY, M ;

STERNAU, L .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 1995, 119 (06) :779-785

[2]

DELAMONTE SM, 1984, AM J PATHOL, V114, P131

[3]

Di Leo A, 2002, CLIN CANCER RES, V8, P1107

[4] PROGNOSTIC IMPORTANCE OF C-ERBB-2 EXPRESSION IN BREAST-CANCER [J].

GUSTERSON, BA ;

GELBER, RD ;

GOLDHIRSCH, A ;

PRICE, KN ;

SAVESODERBORGH, J ;

ANBAZHAGAN, R ;

STYLES, J ;

RUDENSTAM, CM ;

GOLOUH, R ;

REED, R ;

MARTINEZTELLO, F ;

TILTMAN, A ;

TORHORST, J ;

GRIGOLATO, P ;

BETTELHEIM, R ;

NEVILLE, AM ;

BURKI, K ;

CASTIGLIONE, M ;

COLLINS, J ;

LINDTNER, J ;

SENN, HJ .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) :1049-1056

[5] Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables [J].

Ménard, S ;

Valagussa, P ;

Pilotti, S ;

Gianni, L ;

Biganzoli, E ;

Boracchi, P ;

Tomasic, G ;

Casalini, P ;

Marubini, E ;

Colnaghi, MI ;

Cascinelli, N ;

Bonadonna, G .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :329-335

[6] Symptomatic pituitary metastases [J].

Morita, A ;

Meyer, FB ;

Laws, ER .

JOURNAL OF NEUROSURGERY, 1998, 89 (01) :69-73

[7] erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer [J].

Paik, SM ;

Bryant, J ;

Park, CH ;

Fisher, B ;

Tan-Chiu, E ;

Hyams, D ;

Fisher, ER ;

Lippman, ME ;

Wickerham, DL ;

Wolmark, N .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1361-1370

[8]

PRITCHARD K, 2002, P AM SOC CLIN ONCOL, V21

[9] HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE [J].

SLAMON, DJ ;

CLARK, GM ;

WONG, SG ;

LEVIN, WJ ;

ULLRICH, A ;

MCGUIRE, WL .

SCIENCE, 1987, 235 (4785) :177-182

[10] ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2 -: Poor responsiveness to chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil is associated with ErbB2 overexpression and with p21Cip1 overexpression [J].

Yang, WT ;

Klos, KS ;

Zhou, XY ;

Yao, J ;

Yang, Y ;

Smith, TL ;

Shi, D ;

Yu, DH .

CANCER, 2003, 98 (06) :1123-1130

← 1 →